USD
( +0.00%
At Close (As of Jan 1, 1970)
$7.63B
Market Cap
-
P/E Ratio
-5.09
EPS
$194.88
52 Week High
$131.60
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $1B |
Total Revenue | $2.1B |
Cost Of Revenue | $1.1B |
Costof Goods And Services Sold | $1.1B |
Operating Income | -$267M |
Selling General And Administrative | $744M |
Research And Development | $223M |
Operating Expenses | $1.3B |
Investment Income Net | - |
Net Interest Income | -$39M |
Interest Income | $4.8M |
Interest Expense | $44M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $103M |
Income Before Tax | -$305M |
Income Tax Expense | -$400K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$305M |
Comprehensive Income Net Of Tax | - |
Ebit | -$262M |
Ebitda | -$159M |
Net Income | -$305M |
Field | Value (USD) |
---|---|
Total Assets | $2.6B |
Total Current Assets | $1.2B |
Cash And Cash Equivalents At Carrying Value | $178M |
Cash And Short Term Investments | $178M |
Inventory | $459M |
Current Net Receivables | $489M |
Total Non Current Assets | $1.4B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $558M |
Intangible Assets Excluding Goodwill | $558M |
Goodwill | $97M |
Investments | - |
Long Term Investments | $8.6M |
Short Term Investments | - |
Other Current Assets | $100M |
Other Non Current Assets | - |
Total Liabilities | $1.6B |
Total Current Liabilities | $618M |
Current Accounts Payable | $253M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $59M |
Total Non Current Liabilities | $956M |
Capital Lease Obligations | $81M |
Long Term Debt | $728M |
Current Long Term Debt | $37M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $846M |
Other Current Liabilities | $204M |
Other Non Current Liabilities | $3.6M |
Total Shareholder Equity | $1.1B |
Treasury Stock | - |
Retained Earnings | $1.5B |
Common Stock | $100K |
Common Stock Shares Outstanding | $53M |
Field | Value (USD) |
---|---|
Operating Cashflow | $196M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $103M |
Capital Expenditures | $20M |
Change In Receivables | - |
Change In Inventory | -$7.5M |
Profit Loss | - |
Cashflow From Investment | -$51M |
Cashflow From Financing | -$126M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$305M |
Field | Value (USD) |
---|---|
Gross Profit | $1B |
Total Revenue | $2.1B |
Cost Of Revenue | $1.1B |
Costof Goods And Services Sold | $1.1B |
Operating Income | -$267M |
Selling General And Administrative | $744M |
Research And Development | $223M |
Operating Expenses | $1.3B |
Investment Income Net | - |
Net Interest Income | -$39M |
Interest Income | $4.8M |
Interest Expense | $44M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $103M |
Income Before Tax | -$305M |
Income Tax Expense | -$400K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$305M |
Comprehensive Income Net Of Tax | - |
Ebit | -$262M |
Ebitda | -$159M |
Net Income | -$305M |
Field | Value |
---|---|
Ex Dividend Date | 2012-11-23 |
Declaration Date | None |
Record Date | None |
Payment Date | None |
Amount | 1.0 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Masimo Corporation is a leading innovator in non-invasive monitoring technologies, providing advanced solutions that enhance patient care and streamline healthcare operations worldwide. Headquartered in Irvine, California, Masimo's cutting-edge products, including its proprietary pulse oximetry and non-invasive biometrics, are widely utilized in hospitals and other clinical settings. With a commitment to improving patient outcomes and driving efficiency, the company continues to expand its offerings in the rapidly evolving healthcare technology landscape.